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Accepted 17 October 2012AbstractObjective: Uterine myoma is the most common benign reproductive tract tumor in women. Despite its high prevalence, the exact pathogenesis of
these benign tumors remains unknown. Toward understanding the pathogenic mechanism of these tumors, we attempted to isolate human uterine
myoma mesenchymal stem cells (hUM-MSCs), which may be the target cells for tumorigenesis. Furthermore, we tested the response of these
hUM-MSCs to the environmental endocrine disruptor, bisphenol A (BPA), which may mimic the action of estrogen in hormone-sensitive organs
such as the uterus.
Materials and Methods: The hUM-MSC lines were clonally derived from uterine myoma tissue using the MSU-1 medium supplemented with N-
acetyl-L-cysteine and L-ascorbic acid-2-phosphate. These hUM-MSCs were characterized by reverse transcription polymerase chain reaction
(RT-PCR) analysis for the expression of mesenchymal stem cell (MSC) surface markers (e.g., CD90 and CD105) and the transcription factor
Oct-4. The proliferation potential was measured by the cumulative population doubling level and the colony-forming efficiency.
Results: Putative hUM-MSC lines expressed CD90, CD105, and the stem cell marker gene, Oct-4. The cells were capable of differentiating into
adipocytes, osteoblasts, and chondrocytes. Bisphenol A treatment of these hUM-MSCs enhanced cell proliferation and colony-forming effi-
ciency in a dose-responsive manner. At an environmentally relevant concentration (108 M), BPA moreover induced cyclooxygenase-2 (COX-2)
gene expression and promoted cell migration and invasiveness.
Conclusion: The hUM-MSC cell lines can be isolated from uterine myoma tissues. Bisphenol A could enhance cell proliferation and colony-
forming efficiency, induce COX-2 gene expression, and promote migration and invasion of hUM-MSCs. The results imply that BPA has a
detrimental effect on female health by promoting uterine tumorigenesis.
Copyright  2013, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Stem cells are undifferentiated cells with the capacity for
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http://dx.doi.org/10.1016/j.tjog.2013.04.016to differentiated cells. In recent years, tumor stem cells have
been reported for many different tumors [1e8]. Many tumor
stem cell markers are also markers of normal stem cells in
different tissues [9e14], a major evidence supporting the hy-
pothesis that stem cells are the tumor-initiating target cells
[15,16].
A uterine myoma (i.e., a uterine fibroid) is a benign tumor
of the female reproductive tract. Despite the high prevalencecs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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known [17]. One possible mechanism for uterine myoma
formation is the dysregulation of stem cell activity. Evidence
for the presence of uterine stem cells has been previously
reviewed [18] and reported, and include eutopic and ectopic
endometrial tissue [19], endometrial carcinoma [20], myo-
metrium tissue [21], and myoma [22].
Mesenchymal stem cells (MSCs) have been defined by the
International Society for Cellular Therapy [23] as possessing
three characteristics, namely: (1) they are plastic-adherent; (2)
they express CD90 and CD105, but not CD34 and CD45; and
(3) they are able to differentiate into osteoblasts, adipocytes,
and chondroblasts in vitro. The most common source of MSCs
is the bone marrow [24]. Mesenchymal stem cells have been
derived from various tissues such as adipose tissue [25], li-
poma [26], cord blood [27], skeletal muscle, dermis [28], sy-
novial membrane [29], placenta [30], amniotic fluid [31],
eutopic and ectopic endometrial tissues [19], and peripheral
blood [32].
Environmental endocrine disruptors (EEDs) include many
environmental estrogens or xenoestrogens that mimic the ac-
tion of natural estrogen hormone in the body. Bisphenol A
(BPA), one of the most important EEDs, is widely used as a
material for the production of epoxy resins and polycarbonate
plastics. It has been detected in many human tissue compart-
ments such as serum, follicular fluid, amniotic fluid [33,34],
urine [35], breast milk [36], saliva [37], and adipose tissue [38]
at concentrations ranging from 0.5 nM to 40 nM [34,39e43].
The consequence of BPA exposure in human reproduction
remains controversial, although BPA exposure reportedly may
be associated with recurrent miscarriages, endometrial hy-
perplasia, obesity, and polycystic ovarian syndrome (PCOS)
[33,44e46].
In this study, we have developed a technique to isolate
human uterine myoma tissue-derived mesenchymal stem cells
(hUM-MSCs). This provides an opportunity to analyze the
effects of BPA on hUM-MSCs.
Materials and methodsPrimary culture cells derived from human uterine
myoma tissueHuman uterine myoma tissue primary cells were isolated
from five patients receiving surgery to treat uterine myoma in
the Department of Obstetrics and Gynecology of Kuo General
Hospital, Tainan, Taiwan. The use of these tissues has been
approved by the Institutional Review Board (IRB). A small
amount of uterine myoma tissue (approximately 5 grams) was
minced by sterile scissors, and then subjected to overnight
digestion at 37C with collagenase Type I (1 mg/mL) in
phenol red-free Dulbecco’s modified Eagle’s medium/F-12
medium (DMEM/F-12 medium) (5 mL medium per 1 g of
tissue). The digested tissue was filtered through a sterile 100-
mm polyethylene mesh filter to remove undigested tissues, and
again filtered through a 40-mm cell strainer to remove
epithelial cells. The primary cells in the filtrate were collectedby centrifugation and re-suspended in phenol red-free DMEM/
F-12 medium supplemented with 10% fetal bovine serum
(FBS). On the next day, unattached cells were removed by
washing them with phosphate-buffered saline (PBS). The
medium was changed every other day, and the cells were
allowed to grow until near confluence. After 1 week, the pri-
mary cell cultures were trypsinized and stored in liquid ni-
trogen or subcultured for further experiments.Isolation and culture of hUM-MSCsTo isolate hUM-MSCs, the primary cell cultures were
diluted and seeded in a 96-well plate at a density of one cell
per well. All wells were examined under the microscope for
the number of attached cells. Wells without cells or with more
than one cell were marked and disregarded. The medium was
changed to the basic MSU-1 (i.e., phenol red-free) medium
[47,48] with 5% FBS, 2 mM N-acetyl-L-cysteine (NAC) and
0.2 mM L-ascorbic acid-2-phosphate (Asc-2P). After incuba-
tion for 14 days, proliferating cells clonally derived from one
single cell were trypsinized and cultured in a 60-mm Petri
dish. The medium was renewed every other day and the cells
were allowed to grow until near confluence. Three hUM-MSC
culturesdhUM-MSC1, hUM-MSC2 and hUM-MSC3dwere
eventually obtained by this procedure. Early passage cells (i.e.,
passage 2) were used in subsequent experiments.Cumulative population doubling levelThe cumulative population doubling level (cpdl) in
continual subcultures and growth from a known number of
cells (1  105) were calculated to determine the proliferation
potential of hUM-MSCs. The cpdl of each subculture was
calculated from the cell count by using the following equation:
ln (Nf/Ni)/ ln2
in which Ni and Nf are the initial and final cell numbers,
respectively, and ln is the natural logarithm [19,49].Cell proliferation assayTo examine the self-renewal capacity, the hUM-MSCs were
treated for 7 days with various concentrations of 17-b-estra-
diol (E2), BPA (1  104 M, 1  105 M, 1  106 M,
1  107 M, 1  108 M, 1  109 M, and 1  1010 M
dissolved in dimethyl sulfoxide [DMSO]) or treated with the
solvent vehicle DMSO (0.1%) as the negative control. The
growth rates of the cell cultures were calculated by dividing
the cpdl by the number of days that elapsed during the culture
[19,47]. At least three independent experiments were per-
formed for each study.Colony formation assayTo test the effect of BPAon colony-forming ability, the hUM-
MSCs cellswere plated at a density of 100 viable cells per 10-cm
dish in amediumwithout orwithBPA (1 104M, 1 105M,
1  106 M, 1  107 M, 1  108 M, 1  109 M, and
248 K.-H. Wang et al. / Taiwanese Journal of Obstetrics & Gynecology 52 (2013) 246e2521  1010 M). After 21 days, the colonies were stained with
0.5% crystal violet stain. The colonies on the plates were pho-
tographed and counted to compare the colony-forming effi-
ciency [19,47]. At least three independent experiments were
performed for each study.Multilineage differentiation potential of hUM-MSCsThe hUM-MSCs cells were tested for their mesodermal
multilineage differentiation potential (i.e., adipogenesis,
osteogenesis, and chondrogenesis). Cells were first sub-
cultured and incubated in modified Eagle’s medium (i.e., the
D-medium) [50] with 10 % FBS. The next day, differentiation
induction was initiated by changing the medium with different
supplementations [19,25,49].AdipogenesisThe hUM-MSCs were plated at a seeding density of 5  104
cells/cm2 in 35-mm Petri dishes. The next day, the cells were
incubated in IDII medium for 2 days, and then in I medium for 1
day. The cycle of treatment (i.e., 3 days) was repeated four times.
The IDII medium contains 3-isobutyl-1-methylxanthine
(500 mM), dexamethasone (1 mM), indomethacin (1 mM), and
insulin (10mg/mL) inD-mediumwith 10%FBS. The Imedium is
the D-medium supplemented with 10% FBS and insulin (10 mg/
mL). Oil Red O staining (indicated by red stain) verified the
development of lipid vacuoles within adipocytes after induction.OsteogenesisThe hUM-MSCs were plated at a seeding density of 5  104
cells/cm2 in 35-mm Petri dishes. On the following day, the cells
were induced to differentiate in DAG medium for 2 weeks. The
medium was changed once every 3 days. The DAG medium
contains 0.1 mM dexamethasone, 50 mM L-ascorbic acid-2-
phosphate, and 10 mM b-glycerophosphate disodium in D-me-
dium with 10% FBS. The formation of calcified extracellular
matrix (ECM) by osteoblasts was visible and can be confirmed
by von Kossa staining (indicated by black stain).ChondrogenesisMicromass cultures of cells (1  105 cells/10 mL) were
incubated and formed in 24-well plates for 2.5 hours, and then
induced to differentiate in TAI medium for 2 weeks. The
medium was changed once every 3 days. The TAI medium
contained 10 ng/mL TGF-b1, 50 mM L-ascorbic acid-2-
phosphate, and 6.25 mg/mL insulin in D-medium with 10%
FBS. The micromass was stained with Alcian blue for the
presence of sulfated proteoglycan-rich matrix (indicated by
blue stain).Migration and invasion assayCells were inoculated into 24-well Falcon Migration inserts
(1  104 cells/well) and Matrigel Invasion inserts (1  105cells/well) (8-mm pore size in both inserts). Inserts were placed
into Falcon companion plates and incubated for 18 hours for
migration and 24 hours for invasion. After incubation, the
medium and cells were removed from the top chamber by
using cotton swabs and PBS. The number of cells that had
invaded or migrated to the underside of the membrane were
counted and recorded as the average number of migrating or
invading cells per plate in triplicate plates [19,47,48,51].Reverse transcription-polymerase chain reactionTotalRNAwas extracted fromcells byusing 1mLTRIzol. The
RNA (1 mg) was transcribed into cDNA with a reverse tran-
scription system kit, and cDNAwas amplified with gene-specific
primers in a polymerase chain reaction (PCR) machine. The
primers included Oct-4 (forward, 5ʹ-GGCTTGGAGACCTCT
CAGCCTG; reverse, 5ʹ-TGCAGCAAGGGCCGCAGCTTAC),
CD90 (forward, 5ʹ-TCGCTCTCCTGCTAACAGTCT; reverse,
5ʹ-CTCGTACTGGATGGGTGAACT), CD105 (forward, 5ʹ-TG
TCTCACTTCATGCCTCCAGCT; reverse, 5ʹ-AGGCTGTCCA
TGTTGAGGCAGT),COX-2 (forward, 5ʹ-AGGGCCAGCTTTC
ACCAAC; reverse, 5ʹ-AAGGCGCAGTTTACGCTGTC), and
b-actin (loading control) (forward, 5ʹ-ATGATATCGCCGCGC
TCGTCGTC; reverse, 5ʹ-CGCTCGGCCGTGGTGGTGAA).
The amplified products were separated on 2% agarose gels and
stained with ethidium bromide.Statistical analysisThe results show the representatives of at least three sepa-
rate experiments. The significance of difference between
treatments was assessed by the Mann-Whitney test of
nonparametric statistics and was performed by using the SPSS
for Windows 13.0 statistics program (SPSS Inc., Chicago, IL,
USA). A p value <0.05 was considered significant. All sta-
tistical data are presented as the mean  the standard deviation.
ResultsMorphology of the primary cells and hUM-MSCsPrimary cells and hUM-MSCs were isolated from human
uterine myoma tissue, as described in theMaterials andmethods
section. Five primary cell cultures and three clonally derived
hUM-MSC cell linesdhUM-MSC1, hUM-MSC2 and hUM-
MSC3dwere obtained by this procedure. In the following ex-
periments, either all three hUM-MSC cell lines or just the hUM-
MSC2 cell line was used as the representative cells for some
studies. The primary cells were morphologically flat and large
(Fig. 1A), whereas the hUM-MSCs were morphologically
mostly fibroblast-like, but with a few serpiginous cells (i.e., cells
with two long tails), and tended to show contact-insensitive
growth (i.e., piling up) (Fig. 1A). As observed previously [25],
some MSCs may appear as serpiginous cells. These serpiginous
cells may divide symmetrically to give rise to two serpiginous
cells ormay divide asymmetrically to give rise to one serpiginous
cell and one cuboidal cell [19,25,49].
Fig. 1. Morphology and stem cell characteristics of hUM-MSCs. (A) The
morphology of primary cells is flat and large, whereas the morphology of
hUM-MSCs is fibroblastlike or serpiginous. (B) Reverse transcription-
polymerase chain reaction (RT-PCR) analysis shows that, in contrast to pri-
mary cells, hUM-MSC2 cells express Oct-4 mRNA. The hUM-MSC1 and
hUM-MSC3 cells have similar results (data are not shown). (C) The cumu-
lative population doubling level of hUM-MSC1, hUM-MSC2, and
hUM-MSC3 cells reached 20.6, 23.9, and 19.7, respectively, in 48 days
(6 passages). hUM-MSC ¼ human uterine myoma mesenchymal stem cell.
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marker that is expressed in embryonic stem cells, in germ cells
[52], inmany adult humanstemcells [53], and in cancer stemcells
[47,48]. Oct-4 expression appears essential for maintaining an
undifferentiated state and preventing the differentiation of stem
cells [54]. Based onRT-PCRanalysis in this study, theOct-4 gene
is expressed in hUM-MSCs, but not in primary cells (Fig. 1B).Proliferation potential of hUM-MSCsStem cells are characterized by an extensive ability for self-
renewal. To determine the proliferation potential of hUM-
MSCs, the cumulative population doubling level (cpdl) of
three hUM-MSC lines were measured in six passages during 48
days of cell growth. The cpdl for hUM-MSC1, hUM-MSC2,
hUM-MSC3 were 20.6, 23.9, and 19.7, respectively (Fig. 1C).Fig. 2. In vitro differentiation and expression of MSC genes of hUM-MSCs.
(A) The hUM-MSCs were induced to differentiate into the following mesen-In vitro differentiation and expression of MSC genes of
hUM-MSCschymal lineages: adipocytes (stained red by using Oil Red O staining of lipid
droplets); osteoblasts (stained black by using von Kossa staining of calcified
extracellular matrix [ECM]); and chondroblasts (stained blue by using Alcian
blue staining of sulfated proteoglycans). (B) Reverse transcription-polymerase
chain reaction (RT-PCR) analysis indicated CD90 and CD105 mRNA
expression in the hUM-MSC2 cell lines. BPA ¼ bisphenol A; hUM-
MSC ¼ human uterine myoma mesenchymal stem cell.The qualifying criteria for cells to be considered asMSCs are
(1) the ability to differentiate into cells of multiple tissue line-
ages and (2) the expression of CD90 and CD105 [23]. To
demonstrate that the hUM-MSCs are capable of multilineage
differentiation, they were grown in D-medium with differentsupplementations to induce differentiation. After inductionwith
specific medium supplementations, as described in the Mate-
rials and methods section, the hUM-MSCs differentiated into
adipocytes, osteoblasts, and chondroblasts, as indicated by
positive staining with Oil Red O (for lipid droplets), with von
Kossa (for calcified ECM), and with Alcian blue (for sulfated
proteoglycan), respectively (Fig. 2A). By RT-PCR analysis,
specific MSC markers (i.e. CD90 and CD105), were expressed
in the hUM-MSC2 (Fig. 2B). CD90 and CD105 were also
expressed in hUM-MSC1 and hUM-MSC3 (data are not shown).BPA enhances the growth rate and clonogenic ability of
hUM-MSCs in a dose-responsive mannerThe growth response of hUM-MSC2 to E2 and BPA con-
centrations ranging from 1010 M to 104 Mwas analyzed. The
results showed that E2 concentrations from 1010 M to 105 M
significantly increased cell growth, compared to the vehicle
control. The optimum dose was from 108 M to 106 M. The
BPA treatment (at a concentration of 108 M to 105 M) of
hUM-MSC2 cells also significantly increased cell growth. Both
chemicals inhibited cell growth at 104 M (Fig. 3A). In the
clonogenic assay, E2 andBPA significantly increased the colony
formation of hUM-MSC2 cells in a dose-responsivemanner at a
concentration range of 1010 M to 106 M (Fig. 3B). In the
tested dose range, the effects of E2 were more significant than
the effects of BPA. A BPA concentration of 104 M inhibited
clonogenic ability. The effective concentration of BPA at
108 M is considered an environmentally relevant dose and was
used for subsequent experiments.BPA at an environmentally relevant dose induced
cyclooxygenase-2 (COX-2) gene expression in hUM-
MSCs cellIn the medical literature, prolonged exposure of breast stem
cells to E2 could enhance COX-2 expression [47]. Many
Fig. 3. Bisphenol A (BPA) enhances the growth rate and clonogenic ability of hUM-MSCs. (A) The effect of 17-b-estradiol (E2) or BPA on cell proliferation in
hUM-MSC2 cells. The cells treated with various concentrations of E2 or BPA for 7 days were subjected to the proliferation assay. The ratio of the value for the E2-
treated or BPA-treated cells to the value for the control cells (i.e., DMSO-treated cells) was calculated. These are shown on the ordinate. Values are presented as the
mean  standard deviation (SD) (n ¼ 3, different cultures). (B) The hUM-MSC2 cells treated with various concentrations of E2, BPA, or DMSO (0.1%). After 21
days, colonies of cells were stained with 0.5% crystal violet. The values are presented as the mean  SD (n ¼ 3, different cultures). BPA ¼ bisphenol A;
DMSO ¼ dimethyl sulfoxide; E2 ¼ 17-b-estradiol; hUM-MSC ¼ human uterine myoma mesenchymal stem cell. *p < 0.05.
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natural hormone estrogens such as E2 in the body. Therefore,
we investigated the effect of BPA treatment on COX-2
expression in hUM-MSCs. After treatment with BPA
(108 M) for two weeks, the COX-2 mRNA level in hUM-
MSC2 cells was significantly increased, based on RT-PCR
analysis (Fig. 4A). Similar results were obtained for hUM-
MSC1 and hUM-MSC3 (data are not shown).BPA at an environmentally relevant dose enhances the
migration and invasion ability of hUM-MSCs cellsThe effects of BPA to promote cell migration and invasion
ability of hUM-MSCs were examined by using migration and
invasion chamber assays. The results reveal that BPAFig. 4. BPA induces COX-2 gene expression and promotes the migration and
invasion of hUM-MSCs. (A) Reverse transcription-polymerase chain reaction
(RT-PCR) analysis shows that the COX-2 mRNA expression is significantly
elevated in hUM-MSC2 cells treated with BPA (108 M) for 2 weeks,
compared to the controls (i.e., without BPA treatment). (B) Based on migration
and invasion chamber assay, hUM-MSC2 cells treated with BPA (108 M) for
two weeks have significantly enhanced cell migration and invasion. The values
are presented as the mean  standard deviation (SD) (n ¼ 3, different cul-
tures). BPA ¼ bisphenol A; hUM-MSC ¼ human uterine myoma mesen-
chymal stem cell. *p < 0.05.(108 M) treatment of hUM-MSC2 for two weeks significantly
increased cell migration ability, compared to hUM-MSC2
without treatment (2.5% vs. 1.6%, respectively) (Fig. 4B).
The same concentration of BPA similarly significantly
enhanced the invasion ability of hUM-MSC2 (0.238% vs.
0.086% for the control) (Fig. 4B).
Discussion
This study demonstrated that MSCs can be isolated from
human uterine myoma tissue by using the basic MSU-1 me-
dium [47,48,55] supplemented with 5% FBS, 2 mM NAC, and
0.2 mM Asc-2P. The MSU-1 medium without NAC and Asc-
2P was first used in developing human breast epithelial stem
cells [55]. We previously used a keratinocyte medium sup-
plemented with NAC and Asc-2P to develop MSCs from
human and other mammalian adipose tissues [25,26,49,56,57].
The success of developing these MSCs using these media is
ascribed to using NAC [58,59] and Asc-2p [60e62] antioxi-
dants which maintain a cellular redox state that is essential for
stem cell self-renewal [58].
The hUM-MSCs in this study possessed many MSC phe-
notypes. First, the cells showed a high proliferation potential
(more than 20e24 cpdl for the three clonally derived hUM-
MSC cell lines that were examined). Second, the cells were
fibroblast-like or serpiginous with a morphology similar to
adipose tissue-derived human MSCs [25], lipoma [26], and
eutopic or ectopic endometrial tissue [19]. They showed
contact-insensitive growth (i.e., piling up). Third, the hUM-
MSCs expressed MSC markers (i.e., CD90 and CD105) and
the stem cell marker Oct-4, which is expressed in many adult
human and canine stem cells [53,56]. Fourth, and most
importantly, the hUM-MSCs were capable of differentiating
into three major mesodermal cell lineages: adipocytes, oste-
oblasts, and chondroblasts.
Using the hUM-MSCs, we tested the effect of BPA on gene
expression and on phenotypic changes. The results show that
BPA increased hUM-MSC proliferation and colony-forming
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BPA exposure at environmentally relevant doses induced COX-
2 gene expression and promoted the migration and invasion
ability of hUM-MSCs. It has been reported previously that BPA
could promote proliferation of MCF-7 cells [63], HeLa cells
[64], OVCAR-3 cell line [65], neuroblastoma [66], and JKT-1
cells [67]. The growth-promoting effect of BPA on hUM-
MSCs has not been reported previously. In the future, the re-
sults derived from experiments using hUM-MSC2 may be
confirmed by using the other 2 hUM-MSC lines.
The elevated expression of COX-2 could elicit many effects
such as the promotion of tumor progression by inducing in-
vasion and angiogenesis, the suppression of host immunity, the
resistance to apoptosis, and the epithelial to mesenchymal
transition (see references cited in Wang et al [47]). We pre-
viously reported that interleukin-1 beta could induce COX-2
overexpression and promote tumor invasion [51]. The results
of this study indicate that long-term exposure of hUM-MSCs
to BPA at environmentally relevant doses may induce COX-
2 gene expression and may enhance invasion ability, which is
consistent with previous reports [51,68].
In conclusion, we have developed a technique to isolate
clonally derived hUM-MSC lines. We further demonstrated
that BPA could enhance cell proliferation and colony-forming
efficiency, induce COX-2 gene expression, and promote
migration and invasion ability of hUM-MSCs. The results
provide evidence that BPA could promote uterine tumor
growth. These hUM-MSC lines could be useful for detecting
environmental endocrine disruptors or toxicants that promote
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